Viana, Valéria Goulart, et al. “ORAL GLP-1 RECEPTOR AGONIST (ORFORGLIPRON) IN THE MANAGEMENT OF OBESITY AND TYPE 2 DIABETES”. Seven Editora, Jan. 2026, pp. 43-55, https://sevenpubl.com.br/editora/article/view/8968.